LOGO 200
Generic Name: sorafenib
Pill imprint LOGO 200 has been identified as Nexavar 200 mg.
Nexavar is used in the treatment of renal cell carcinoma; hepatocellular carcinoma; thyroid cancer; hepatic tumor and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy.
Nexavar 200 mg is not subject to the Controlled Substances Act.
See also related documents.
Nexavar Images
- Generic Name:
- sorafenib
- Imprint:
-
LOGO
200 - Strength:
- 200 mg
- Color:
- Red
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Multikinase inhibitors
VEGF/VEGFR inhibitors - Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Bayer HealthCare Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00026-8488
Advertisement
More Nexavar resources
Search Again
